Coronary artery bypass grafting ( CABG ) has been considered the standard of care for patients with three-vessel disease ( 3VD ) , but long-term comparative results from randomized trials of CABG vs. percutaneous coronary intervention ( PCI ) using drug-eluting stents ( DES ) remain limited .